Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation. - Wikidata - awgldk - TriplyDB

Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation.

Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation.

http://www.wikidata.org/entity/Q37982346

about

Application of nucleoside analogues to liver transplant recipients with hepatitis B Μanagement of patients with hepatitis B and C before and after liver and kidney transplantation Management of patients with hepatitis B in special populations Clinicopathological features of hepatitis B virus recurrence after liver transplantation: eleven-year experience.HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation.Management of hepatitis B virus infection after liver transplantation.The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence.Hepatitis B immunoglobulin prophylaxis after liver transplantation: experience in a tertiary transplant centre Anti-HBs response to hepatitis B immunoglobulin prophylaxis in liver transplant recipients.Prevention and risk factors of hepatitis B recurrence after living donor liver transplantation.

P2860

Q26859796-D5FA62C5-3D0A-4CBA-8E1E-A0A73C69A41B Q26864647-5AD50162-794F-4104-8480-363810C6C314 Q27016136-BB84929F-1602-439D-9D08-C13949B12E45 Q34029115-F0959B07-E27F-482A-AEFD-07B2B26A948F Q38218762-082DD82C-7600-419A-8475-3CF685AD6757 Q38635614-74E92744-0430-4A0C-820B-4B83F983A149 Q40654117-5FE001EF-F97F-484C-B647-71830973C5F0 Q41835680-E9F5F820-6A8B-470B-B40C-D894BD32ED05 Q42222635-1385E23C-A639-4CD5-AD4F-094B54955835 Q42263202-C4956632-42CB-4E4B-8F0F-A36D860E0401

P2860

Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation.

http://www.wikidata.org/entity/Q37982346

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Immunoprophylaxis against and ...... s after liver transplantation.

@en

Immunoprophylaxis against and ...... s after liver transplantation.

@nl

type

label

Immunoprophylaxis against and ...... s after liver transplantation.

@en

Immunoprophylaxis against and ...... s after liver transplantation.

@nl

prefLabel

Immunoprophylaxis against and ...... s after liver transplantation.

@en

Immunoprophylaxis against and ...... s after liver transplantation.

@nl

P1433

Q37982346-02E4C658-F6F5-467D-BFA5-EA63FF66D85F

P1476

Q37982346-6C42FA86-64B3-4D6C-B495-3B083E488DF4

P2093

Q37982346-358371BE-155A-4001-836A-93FD0BFAE643

Q37982346-B5E3BE40-ADF2-4FEF-99B4-F561B7C37A6C

P2860

Q37982346-037B4849-C364-4266-B48E-906ED21AC3FE

Q37982346-043C8BB3-79C9-419F-B770-44490C416C76

Q37982346-0A0086EE-7F86-4F35-8F9E-1FB6FFBBCA36

Q37982346-104863D2-D312-4649-ACA2-D9A42B112D7F

Q37982346-11228D00-8148-421F-94AD-D5FD9DFCC5C0

Q37982346-1702C3D9-4CDB-49A8-A849-3BFCF35B7780

Q37982346-1A4F7E04-1F4F-47B6-A6B4-D140A86D4EE9

Q37982346-1E74305E-794E-4183-9CA6-5DFAA57495C6

Q37982346-22D262AE-D0A9-47D9-971C-620F7232C479

Q37982346-2994D167-5BBF-407A-980B-E1929E73EAC6

P304

Q37982346-6EBB0FF7-CE70-4206-87BC-D23EA8B4B185

P31

Q37982346-B965564E-1BA0-4B19-940B-C5A0CC139438

P356

Q37982346-E4C57464-2B42-4426-837C-F0743BAFC01F

P433

Q37982346-921B7E0B-57D9-4E61-A28F-FCF5585877FE

P478

Q37982346-1C124230-7D10-445A-B638-3D2F1750781C

P577

Q37982346-C801B355-9BB3-41AF-9533-D37408098A69

P5875

Q37982346-22A82155-C2CB-42EF-9579-914C7E0898C8

P698

Q37982346-CAF77E53-1C1F-49F9-8836-C6ECFCD7110D

P921

Q37982346-E734F5B9-994F-422B-AA7C-438EAAA6AC2B

P356

P1433

Liver Transplantation

P1476

Immunoprophylaxis against and ...... s after liver transplantation.

@en

P2093

Kymberly D Watt

http://www.w3.org/2001/XMLSchema#string

Marie A Laryea

http://www.w3.org/2001/XMLSchema#string

P2860

Preclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant Patients

Chronic hepatitis B: update 2009

Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.

Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation.

An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.

Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review.

Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy.

Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis

Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis.

P304

514-523

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/LT.23408

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221815385

http://www.w3.org/2001/XMLSchema#string

P698

22315212

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation